• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高德瑞蒂斯比值与成年创伤患者的死亡率相关。

A High De Ritis Ratio is Associated with Mortality in Adult Trauma Patients.

作者信息

Tsai Ching-Hua, Hsieh Ting-Min, Hsu Shiun-Yuan, Hsieh Ching-Hua

机构信息

Department of Trauma Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan.

出版信息

Risk Manag Healthc Policy. 2023 May 12;16:879-887. doi: 10.2147/RMHP.S409345. eCollection 2023.

DOI:10.2147/RMHP.S409345
PMID:37205002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10187658/
Abstract

INTRODUCTION

The De Ritis ratio, which is the ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT), has been suggested as a potential prognostic marker for various diseases. This study aimed to investigate the association between the De Ritis ratio and in-hospital mortality in adult trauma patients.

METHODS

A total of 17,472 adult trauma patients hospitalized between January 1, 2009, and December 31, 2020, were allocated into groups according to the De Ritis ratio. The normal range of the De Ritis ratio was calculated from 3320 individuals in the National Taiwan Biobank. Statistical analyses were performed using SPSS software.

RESULTS

Patients with a De Ritis ratio >1.6 had a significantly higher in-hospital mortality rate (7.3% vs 1.5%, odds ratio 5.29; Q1-Q3 2.72-10.30; p < 0.001) and a 2.71-fold higher in-hospital mortality rate (Q1-Q3 1.24-5.92; p = 0.012), after adjusting for sex, age, comorbidities, consciousness level, and injury severity, than those with a De Ritis ratio within the reference values.

DISCUSSION

This study revealed that a De Ritis ratio >1.6 may serve as an early prognostic tool to identify adult trauma patients at high risk of in-hospital mortality.

摘要

引言

德瑞蒂斯比值(De Ritis ratio)是天冬氨酸氨基转移酶(AST)与丙氨酸氨基转移酶(ALT)的比值,已被认为是多种疾病的潜在预后标志物。本研究旨在探讨德瑞蒂斯比值与成年创伤患者院内死亡率之间的关联。

方法

将2009年1月1日至2020年12月31日期间住院的17472例成年创伤患者根据德瑞蒂斯比值分组。德瑞蒂斯比值的正常范围根据台湾生物银行的3320名个体计算得出。使用SPSS软件进行统计分析。

结果

德瑞蒂斯比值>1.6的患者在调整性别、年龄、合并症、意识水平和损伤严重程度后,其院内死亡率显著更高(7.3%对1.5%,比值比5.29;四分位数间距2.72 - 10.30;p<0.001),且院内死亡率高出2.71倍(四分位数间距1.24 - 5.92;p = 0.012),高于德瑞蒂斯比值在参考值范围内的患者。

讨论

本研究表明,德瑞蒂斯比值>1.6可作为一种早期预后工具,用于识别有院内死亡高风险的成年创伤患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae64/10187658/4c1c56ad9aa8/RMHP-16-879-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae64/10187658/59d1a4b1c5ef/RMHP-16-879-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae64/10187658/b1b03d104b28/RMHP-16-879-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae64/10187658/4c1c56ad9aa8/RMHP-16-879-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae64/10187658/59d1a4b1c5ef/RMHP-16-879-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae64/10187658/b1b03d104b28/RMHP-16-879-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae64/10187658/4c1c56ad9aa8/RMHP-16-879-g0003.jpg

相似文献

1
A High De Ritis Ratio is Associated with Mortality in Adult Trauma Patients.高德瑞蒂斯比值与成年创伤患者的死亡率相关。
Risk Manag Healthc Policy. 2023 May 12;16:879-887. doi: 10.2147/RMHP.S409345. eCollection 2023.
2
Association between Elevated De Ritis Ratio and Mortality Outcome in Adult Patients with Thoracoabdominal Trauma.成人胸腹联合伤患者中德瑞蒂斯比值升高与死亡率结局的关联。
Healthcare (Basel). 2022 Oct 19;10(10):2082. doi: 10.3390/healthcare10102082.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
5
Delta De Ritis Ratio Is Associated with Worse Mortality Outcomes in Adult Trauma Patients with Moderate-to-Severe Traumatic Brain Injuries.Delta De Ritis比值与中重度创伤性脑损伤成年创伤患者的更差死亡率结局相关。
Diagnostics (Basel). 2022 Dec 1;12(12):3004. doi: 10.3390/diagnostics12123004.
6
The effectiveness of the De Ritis ratio in diagnosis and follow-up of Celiac disease: A Retrospective Study.德瑞蒂斯比值在乳糜泻诊断及随访中的有效性:一项回顾性研究
Clin Ter. 2025;173(3):310-316. doi: 10.7417/CT.2025.5227.
7
Using Second Measurement of De Ritis Ratio to Improve Mortality Prediction in Adult Trauma Patients in Intensive Care Unit.使用第二次德瑞蒂斯比值测量来改善重症监护病房成年创伤患者的死亡率预测
Diagnostics (Basel). 2022 Nov 24;12(12):2930. doi: 10.3390/diagnostics12122930.
8
Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors.德瑞蒂斯比值在上尿路肿瘤肾输尿管切除术后膀胱复发预测生存中的预后价值
Diagnostics (Basel). 2025 Jul 22;15(15):1840. doi: 10.3390/diagnostics15151840.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.

引用本文的文献

1
Impact of Liver Disease on Use of Muscle Relaxants in Anesthesia: A Comprehensive Review.肝病对麻醉中肌肉松弛剂使用的影响:一项全面综述
Med Sci Monit. 2025 Jan 1;31:e945822. doi: 10.12659/MSM.945822.
2
Navigating Disease Management: A Comprehensive Review of the De Ritis Ratio in Clinical Medicine.疾病管理指南:临床医学中德瑞蒂斯比值的全面综述
Cureus. 2024 Jul 13;16(7):e64447. doi: 10.7759/cureus.64447. eCollection 2024 Jul.

本文引用的文献

1
The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries.肝损伤创伤患者中白蛋白-胆红素(ALBI)分级与死亡风险的关系
Risk Manag Healthc Policy. 2023 Feb 24;16:279-286. doi: 10.2147/RMHP.S397210. eCollection 2023.
2
Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy.天冬氨酸转氨酶/丙氨酸转氨酶比值在乙型肝炎病毒相关性肝细胞癌肝切除患者中的预后价值
Front Oncol. 2022 May 18;12:876900. doi: 10.3389/fonc.2022.876900. eCollection 2022.
3
The Study of De Ritis (Ast/ Alt) Ratio in Comparision with Other Parameters for Predicting Poor Prognosis in Covid 19 Patients.
德瑞蒂斯(AST/ALT)比值与其他参数在预测 COVID-19 患者不良预后中的比较研究。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
4
Elevated De Ritis Ratio Is Associated With Poor Prognosis in COVID-19: A Systematic Review and Meta-Analysis.德瑞蒂斯比值升高与COVID-19的不良预后相关:一项系统评价和荟萃分析
Front Med (Lausanne). 2021 Dec 22;8:676581. doi: 10.3389/fmed.2021.676581. eCollection 2021.
5
Association Between Preoperative De Ritis (AST/ALT) Ratio and Oncological Outcomes Following Radical Cystectomy in Patients With Urothelial Bladder Cancer.术前 De Ritis(AST/ALT)比值与膀胱癌患者根治性膀胱切除术后肿瘤学结局的关系。
Clin Genitourin Cancer. 2022 Apr;20(2):e89-e93. doi: 10.1016/j.clgc.2021.10.007. Epub 2021 Oct 25.
6
Predictive value of aspartate aminotransferase-to-alanine aminotransferase ratio for contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention.天门冬氨酸氨基转移酶/丙氨酸氨基转移酶比值对择期经皮冠状动脉介入治疗患者造影剂相关急性肾损伤的预测价值。
J Cardiol. 2022 May;79(5):618-625. doi: 10.1016/j.jjcc.2021.11.009. Epub 2021 Nov 29.
7
The Role of De Ritis Ratio as a Clinical Prognostic Parameter in COVID 19 Patients.德瑞蒂斯比值作为新冠病毒肺炎患者临床预后参数的作用
Clin Lab. 2021 Oct 1;67(10). doi: 10.7754/Clin.Lab.2021.210119.
8
Elevated De Ritis Ratio as a Predictor for Acute Kidney Injury after Radical Retropubic Prostatectomy.De Ritis比值升高作为耻骨后根治性前列腺切除术后急性肾损伤的预测指标
J Pers Med. 2021 Aug 25;11(9):836. doi: 10.3390/jpm11090836.
9
Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.天门冬氨酸氨基转移酶/丙氨酸氨基转移酶(De Ritis 比值)预测大面积烧伤患者的生存情况。
Burns. 2022 Jun;48(4):872-879. doi: 10.1016/j.burns.2021.08.006. Epub 2021 Aug 18.
10
Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?急性冠状动脉综合征患者血清转氨酶升高:我们是否需要修订临床试验排除标准?
Cardiol J. 2023;30(5):747-752. doi: 10.5603/CJ.a2021.0081. Epub 2021 Aug 6.